研究実績
2024.07.30
A multicenter, placebo-controlled, randomised, double-blind study investigating the efficacy and safety of elobixibat in patients with Parkinson’s disease with chronic constipation （CONST-PD study）.
Hatano T, Oyama G, Ogaki K, Shimo Y, Nishikawa N, Tsunemi T, Hattori N, and CONST-PD investigators. A multicenter, placebo-controlled, randomised, double-blind study investigating the efficacy and safety of elobixibat in patients with Parkinson’s disease with chronic constipation (CONST-PD study). 第64回日本神経学会学術大会. 2023.06.02, 幕張
